EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Phage Therapy: Targeting the Gut Microbiota for the Treatment of Acute Pancreatitis

Jiawei Chen iD, Caihan Duan iD, Keyi Zhang iD, Jun Liu, Chaoqun Han

Journal of Gastroenterology and Hepatology · 2026-05 · 41 (5) · 1446-1458

DOI: 10.1111/jgh.70308 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 21.02.2026. Verfasst von Jiawei Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Pancreatitis, Phage Therapy, Gastrointestinal Microbiome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute pancreatitis (AP) is a common clinical inflammatory condition whose severity is closely associated with both local pancreatic injury and systemic complications. Research indicates that gut microbiota dysbiosis and subsequent bacterial translocation can exacerbate disease progression via the gut–pancreas axis, representing a critical factor influencing patient outcomes. Although antibiotics remain a primary approach for infection control, their extensive use has led to increasingly prominent issues of bacterial resistance, and their broad‐spectrum nature may further disrupt microbial homeostasis. Within this context, phage therapy, by virtue of its high specificity for targeted bacterial elimination, offers a novel approach for precisely modulating the gut microbiota, demonstrating unique therapeutic potential. This review explores the emerging role of phage therapy in regulating the pancreas‐gut axis, focusing on mechanisms such as precise pathogen eradication, immunomodulatory effects, and restoration of microbial equilibrium, thus effectively inhibiting the progression of pancreatitis. Finally, we discuss the challenges and future prospects of translating this promising strategy into clinical practice for AP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatitisPhage TherapyGastrointestinal MicrobiomeHumansAcute DiseaseDysbiosisAnimalsBacterial TranslocationDisease Progression

Stichwörter der Autor:innen

acute pancreatitisdrug resistancedysbiosisgut–pancreas axisimmune effectsphage

Autor:innen und Institutionen

  • Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: Jiawei Chen, Caihan Duan, Keyi Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, J., Duan, C., Zhang, K., Liu, J., & Han, C. (2026). Phage Therapy: Targeting the Gut Microbiota for the Treatment of Acute Pancreatitis. Journal of Gastroenterology and Hepatology, 41(5), 1446-1458. https://doi.org/10.1111/jgh.70308

Vancouver

Chen J, Duan C, Zhang K, Liu J, Han C. Phage Therapy: Targeting the Gut Microbiota for the Treatment of Acute Pancreatitis. Journal of Gastroenterology and Hepatology. 2026;41(5):1446-1458. doi:10.1111/jgh.70308

BibTeX
@article{Chen2026,
  author = {Chen, Jiawei and Duan, Caihan and Zhang, Keyi and Liu, Jun and Han, Chaoqun},
  title = {Phage Therapy: Targeting the Gut Microbiota for the Treatment of Acute Pancreatitis},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {5},
  pages = {1446--1458},
  doi = {10.1111/jgh.70308}
}
Kostenlos starten →